[1] Stark A, Donahue TR, Reber HA, et al.Pancreatic cyst disease: a review[J]. JAMA,2016,315(17):1882-1893.
[2] 彭承宏,郝纯毅,戴梦华,等.胰腺囊性疾病诊治指南(2015)[J]. 中国实用外科杂志,2015,35(9):955-959
[3] Elta GH, Enestvedt BK, Sauer BG, et al.ACG Clinical Guideline: diagnosis and management of pancreatic cysts[J]. Am J Gastroenterol,2018,113(4):464-479.
[4] European Study Group on Cystic Tumours of the Pancreas. European evidence-based guidelines on pancreatic cystic neoplasms[J]. Gut,2018,67(5):789-804.
[5] Kauhanen S, Rinta-Kiikka I, Kemppainen J, et al.Accuracy of 18F-FDG PET/CT, multidetector CT, and MR imaging in the diagnosis of pancreatic cysts: a prospective single-center study[J]. J Nucl Med,2015,56(8):1163-1168.
[6] Saito M, Ishihara T, Tada M, et al.Use of F-18 fluorodeoxyglucose positron emission tomography with dual-phase imaging to identify intraductal papillary mucinous neoplasm[J]. Clin Gastroenterol Hepatol,2013,11(2):181-186.
[7] Antoch G, Bockisch A. Combined PET/MRI: a new dimension in whole-body oncology imaging?[J]. Eur J Nucl Med Mol Imaging,2009,36 Suppl 1:S113-S120.
[8] Nensa F, Beiderwellen K, Heusch P, et al.Clinical applications of PET/MRI: current status and future perspectives[J]. Diagn Interv Radiol,2014,20(5):438-447.
[9] Huo L, Feng F, Liao Q, et al.Intraductal papillary mucinous neoplasm of the pancreas with high malignant potential on FDG PET/MRI[J]. Clin Nucl Med,2016,41(12):989-990.
[10] Khashab MA, Kim K, Lennon AM, et al.Should we do EUS/FNA on patients with pancreatic cysts? The incremental diagnostic yield of EUS over CT/MRI for prediction of cystic neoplasms[J]. Pancreas,2013,42(4):717-721.
[11] Dumonceau JM, Deprez PH, Jenssen C, et al.Indications, results, and clinical impact of endoscopic ultrasound (EUS)-guided sampling in gastroenterology: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline-Updated January 2017[J]. Endoscopy,2017,49(7):695-714.
[12] Hara T, Yamaguchi T, Ishihara T, et al.Diagnosis and patient management of intraductal papillary-mucinous tumor of the pancreas by using peroral pancreatoscopy and intraductal ultrasonography[J]. Gastroenterology,2002, 122(1):34-43.
[13] Okuno N, Hara K, Obata M.A novel method of diagno-sing solid pseudopapillary neoplasms of the pancreas: Needle-based confocal laser endomicroscopy[J]. Dig Endosc,2019.doi: 10.1111/den.13396.
[14] Arnelo U, Siiki A, Swahn F, et al.Single-operator pancreatoscopy is helpful in the evaluation of suspected intraductal papillary mucinous neoplasms(IPMN)[J]. Pancreatology,2014,14(6):510-514.
[15] Hanania AN, Bantis LE, Feng Z, et al.Quantitative ima-ging to evaluate malignant potential of IPMNs[J]. Oncotar-get,2016,7(52):85776-85784.
[16] Malleo G, Bassi C, Rossini R, et al.Growth pattern of serous cystic neoplasms of the pancreas: observational study with long-term magnetic resonance surveillance and recommendations for treatment[J]. Gut,2012,61(5):746-751.
[17] Park JW, Jang JY, Kang MJ, et al.Mucinous cystic neoplasm of the pancreas: is surgical resection recommended for all surgically fit patients?[J]. Pancreatology,2014,14(2):131-136.
[18] Nilsson LN, Keane MG, Shamali A, et al.Nature and management of pancreatic mucinous cystic neoplasm (MCN): A systematic review of the literature[J]. Pancreato-logy,2016,16(6):1028-1036.
[19] Vanella G, Crippa S, Archibugi L, et al.Meta-analysis of mortality in patients with high-risk intraductal papillary mucinous neoplasms under observation[J]. Br J Surg,2018,105(4):328-338.
[20] Schmidt CM, White PB, Waters JA, et al. Intraductal papillary mucinous neoplasms: predictors of malignant and invasive pathology[J]. Ann Surg,2007,246(4):644-651;discussion 651-644.
[21] Kaimakliotis P, Riff B, Pourmand K, et al.Sendai and Fukuoka Consensus Guidelines identify advanced neoplasia in patients with suspected mucinous cystic neoplasms of the pancreas[J]. Clin Gastroenterol Hepatol,2015,13(10):1808-1815.
[22] DeWitt J, DiMaio CJ, Brugge WR. Long-term follow-up of pancreatic cysts that resolve radiologically after EUS-guided ethanol ablation[J]. Gastrointest Endosc,2010,72(4):862-866.
[23] Seo DW. EUS-guided antitumor therapy for pancreatic tumors[J]. Gut Liver,2010,4 Suppl 1:S76-S81.
[24] Vege SS, Ziring B, Jain R, et al. American gastroenterological association institute guideline on the diagnosis and management of asymptomatic neoplastic pancreatic cysts[J]. Gastroenterology,2015,148(4):819-822;quize812-813.
[25] Imbe K, Nagata N, Hisada Y, et al.Validation of the American Gastroenterological Association guidelines on management of intraductal papillary mucinous neoplasms: more than 5 years of follow-up[J]. Eur Radiol,2018,28(1):170-178.
[26] Del Chiaro M, Verbeke C, Salvia R, et al.European experts consensus statement on cystic tumours of the pancreas[J]. Dig Liver Dis,2013,45(9):703-711.
[27] Tanaka M, Fernandez-del Castillo C, Adsay V, et al. International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas[J]. Pancreatology,2012,12(3):183-197.
[28] Tanaka M, Fernandez-Del Castillo C, Kamisawa T, et al. Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreas[J]. Pancreatology,2017,17(5):738-753.
[29] Chen Y, Guo C, Zhang Q, et al.Patients with pancreatic cystic neoplasms can benefit from management of multidisciplinary team: Experience from a Chinese academic center[J]. Pancreatology,2018,18(7):799-804.
